(MedPage Today) — SAN ANTONIO — Remimazolam (Byfavo) is poised to open a new frontier in anesthesiology, but caution is warranted to ensure off-label use does not devolve into the Wild West.
Growing interest in the intravenous sedative-hypnotic…
Source link : https://www.medpagetoday.com/meetingcoverage/asa/117919
Author :
Publish date : 2025-10-13 18:11:00
Copyright for syndicated content belongs to the linked Source.
